Paige
Paige is an AI-enabled digital pathology company focused on **cancer diagnostics**, developing clinical-grade artificial intelligence applications and platforms that assist pathologists and oncologists in detecting, classifying, and quantifying cancer across multiple tissue types, and supporting biomarker discovery and clinical trial work. The company emerged from a collaboration with Memorial Sloan Kettering Cancer Center and leverages one of the largest annotated pathology datasets to train deep-learning models, and it was the **first company to receive FDA clearance/authorization for a clinical AI application in digital pathology**. Paige’s solutions are used by healthcare providers and life sciences organizations globally to improve diagnostic accuracy, efficiency, and therapeutic targeting in oncology.
Company Details
- Website
- paige.ai
- Headquarters
- New York, New York, USA
- Founded
- 2017
- Funding
- $70M+ raised pre-acquisition; acquired by Tempus for approximately $81.25M
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring